A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has been accepted for Priority Review by the US FDA. The application is to ...

Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...

Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...

Chapple has held senior leadership roles at DontBePatient Intelligence, Alira Health, Innovative Trials, Cognizant and ICON ...

How do we translate individual experiences into support that helps others and create support that feels personal but remains ...

Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...

Camena Bioscience, a pioneer in enzymatic DNA synthesis producing complex, high-fidelity gene constructs for AI-driven ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...

A medical communication agency, MedThink SciCom breaks from conventional wisdom to transform scientific exchange. We provide insight generation, strategy and story development, data dissemination, ...

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our planet. But are those connections working for or against your… ...

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder ...